Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
出版年份 2017 全文链接
标题
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-11-07
DOI
10.1038/s41467-017-01582-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
- (2017) Olivier Lortholary et al. LANCET
- Combenefit: an interactive platform for the analysis and visualization of drug combinations
- (2016) Giovanni Y. Di Veroli et al. BIOINFORMATICS
- Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
- (2016) Yuan Wang et al. Drug Design Development and Therapy
- Masitinib for gastrointestinal stromal tumors
- (2016) Mehdi Brahmi et al. Expert Opinion on Orphan Drugs
- Unexpected Off-Targets and Paradoxical Pathway Activation by Kinase Inhibitors
- (2015) Oliver Hantschel ACS Chemical Biology
- A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
- (2015) G. Deplanque et al. ANNALS OF ONCOLOGY
- Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication
- (2014) David A. Nathanson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Small molecule SIRT1 activators for the treatment of aging and age-related diseases
- (2014) Basil P. Hubbard et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Development of New Deoxycytidine Kinase Inhibitors and Noninvasive in Vivo Evaluation Using Positron Emission Tomography
- (2013) Jennifer M. Murphy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural characterization of new deoxycytidine kinase inhibitors rationalizes the affinity-determining moieties of the molecules
- (2013) Julian Nomme et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
- (2012) Raphaël Maréchal et al. GASTROENTEROLOGY
- Viral immune modulators perturb the human molecular network by common and unique strategies
- (2012) Andreas Pichlmair et al. NATURE
- Post-Translational Phosphorylation of Serine 74 of Human Deoxycytidine Kinase Favors the Enzyme Adopting the Open Conformation Making It Competent for Nucleoside Binding and Release
- (2011) Saugata Hazra et al. BIOCHEMISTRY
- Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer
- (2011) Jean-Philippe Spano et al. INVESTIGATIONAL NEW DRUGS
- Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
- (2011) Hedy L Kindler et al. LANCET ONCOLOGY
- Off-target effects of tyrosine kinase inhibitors: Beauty or the Beast?
- (2011) Ranran Zhang et al. LEUKEMIA & LYMPHOMA
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors
- (2010) Kevin A. Hahn et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase
- (2010) Jennifer Sigmond et al. ANTI-CANCER DRUGS
- Turning enzymes ON with small molecules
- (2010) Julie A Zorn et al. Nature Chemical Biology
- Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant
- (2010) Samantha Perez-Miller et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
- (2010) Martine Humbert et al. PLoS One
- Resistance to Imatinib: Mutations and Beyond
- (2010) Paul La Rosée et al. SEMINARS IN HEMATOLOGY
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
- (2009) Patrice Dubreuil et al. PLoS One
- Small-Molecule Activators of a Proenzyme
- (2009) D. W. Wolan et al. SCIENCE
- Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines
- (2008) T. Qin et al. BLOOD
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started